tirzepatide direct from manufacturer Zepbound, a popular weight loss drug, is getting a big price cut — maker Eli Lilly says it will sell one-dose vials of the drug for half the usual monthly list price., Dr. Celine Gounder breaks down Direct-to-Patient Platforms: An Emerging Inflection

To view or add a comment, sign in Health Canada has just approved Jeraygo (aprocitentan) from Idorsia for resistant hypertensionpatients whose blood pressure remains uncontrolled despite being on three or more antihypertensives

But some believe the increased focus on medical treatment could actually shift conversations away from fat-shaming

Some providers extend the 0.25 mg phase to six or eight weeks for patients over 65

In this case, you might get good product, but you are paying middleman margins that eliminate the cost advantage of Chinese sourcing

What Real-World Use Suggests According to general patterns observed in telehealth weight loss programs and clinical practice: First 4-8 weeks: Many people experience appetite reduction and early weight loss (often 5-10 pounds, though individual experiences vary widely)